Sign In
Buy ASRT
$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
Assertio Therapeutics, Inc. (“Assertio” or the “Company”) (ASRT), today announces that it has commenced cash tender offers (the “Offers”) to purchase any and all of the outstanding $42,465
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Enz
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2019 Financial Results
08:02pm, Monday, 09'th Mar 2020
-- Reports Neurology Franchise Annual Net Sales of $108.1 Million, Exceeding Upper End of Prior Guidance -- -- Completed Strategic Asset Sales of NUCYNTA® Franchise and.
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Assertio (ASRT) to Report Q4 Earnings: What's in Store?
03:33pm, Monday, 24'th Feb 2020
During Q4 earnings call, Assertio (ASRT) is likely to provide an update on its recently implemented cost-saving initiatives and the sales performance of its marketed drugs.
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL
Mid-Morning Market Update: Markets Open Lower; US Adds 225,000 Jobs For January
03:10pm, Friday, 07'th Feb 2020
Following the market opening Friday, the Dow traded down 0.65% to 29189.16 while the NASDAQ fell 0.59% to 9516.79. The S&P also fell, dropping 0.57% to 3,326.60.
Leading and...
Bio Roundup: POTUS on Prices, a16z's Fund, Aimmune's Approval & More
12:48pm, Friday, 07'th Feb 2020
The president’s State of the Union address was wide-ranging, as they tend to be, but those who tuned in heard mention of two hot health policy topics:
16 Healthcare Stocks Moving In Friday's Pre-Market Session
12:39pm, Friday, 07'th Feb 2020
Gainers
• Assertio Therapeutics, Inc. (NASDAQ:ASRT) stock increased by 57.7% to $1.64 during Friday's pre-market session.
• Seelos Therapeutics, Inc. (NASDAQ:SEEL)...
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
5 Drug Manufacturers—Specialty & Generic Stocks Moving In Tuesday's After-Market Session
04:34am, Wednesday, 22'nd Jan 2020
Gainers
• Assertio Therapeutics, Inc. (NASDAQ:ASRT) stock moved upwards by 3.1% to $1.34 during Tuesday's after-market session.
Losers
• Durect, Inc. (NASDAQ:...
DDD, NVTA among premarket gainers
02:27pm, Monday, 13'th Jan 2020
Adaptimmune Therapeutics PLC (NASDAQ:ADAP) +56% as SPEAR T-cell platform delivers initial responses in four solid tumors.Verona Pharma PLC (NASDAQ:VRNA) +54% on positive ensifentrine data.Mereo BioP
5 Top NASDAQ Biotech and Pharma Stocks: Neoleukin Up | INN
06:55am, Monday, 16'th Dec 2019
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have moved their share prices.
